Literature DB >> 22146452

Mannose-binding lectin-the forgotten molecule?

Michael Osthoff, George Trendelenburg, Damon P Eisen, Marten Trendelenburg.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22146452     DOI： 10.1038/nm.2588

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  23 in total

Review 1.  C1 inhibitor: biologic activities that are independent of protease inhibition.

Authors:  Alvin E Davis; Shenghe Cai; Dongxu Liu
Journal:  Immunobiology       Date:  2006-12-11       Impact factor: 3.144

2.  Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

Authors:  Giuseppe Castellano; Rita Melchiorre; Antonia Loverre; Pasquale Ditonno; Vincenzo Montinaro; Michele Rossini; Chiara Divella; Michele Battaglia; Giuseppe Lucarelli; Gennaro Annunziata; Silvano Palazzo; Francesco Paolo Selvaggi; Francesco Staffieri; Antonio Crovace; Mohamed R Daha; Maurice Mannesse; Sandra van Wetering; Francesco Paolo Schena; Giuseppe Grandaliano
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

Review 3.  Complement in the brain.

Authors:  Robert Veerhuis; Henrietta M Nielsen; Andrea J Tenner
Journal:  Mol Immunol       Date:  2011-05-04       Impact factor: 4.407

4.  Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke.

Authors:  Alvaro Cervera; Anna M Planas; Carles Justicia; Xabier Urra; Jens C Jensenius; Ferran Torres; Francisco Lozano; Angel Chamorro
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

5.  Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Robert A Matthijsen; Menno P J de Winther; Dian Kuipers; Ingeborg van der Made; Christian Weber; M Veronica Herias; Marion J J Gijbels; Wim A Buurman
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

6.  Recombinant C1 inhibitor in brain ischemic injury.

Authors:  Raffaella Gesuete; Claudio Storini; Alessandro Fantin; Matteo Stravalaci; Elisa R Zanier; Franca Orsini; Helene Vietsch; M L Maurice Mannesse; Bertjan Ziere; Marco Gobbi; Maria-Grazia De Simoni
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

7.  Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells.

Authors:  R A Ezekowitz; K Sastry; P Bailly; A Warner
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

8.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

Review 9.  Mannose-binding lectin deficiency and respiratory tract infection.

Authors:  Damon P Eisen
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

10.  C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation.

Authors:  Katrin Färber; Giselle Cheung; Daniel Mitchell; Russell Wallis; Eberhard Weihe; Wilhelm Schwaeble; Helmut Kettenmann
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164
View more
  1 in total

1.  Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Authors:  Franca Orsini; Pia Villa; Sara Parrella; Rosalia Zangari; Elisa R Zanier; Raffaella Gesuete; Matteo Stravalaci; Stefano Fumagalli; Roberta Ottria; José J Reina; Alessandra Paladini; Edoardo Micotti; Renato Ribeiro-Viana; Javier Rojo; Vasile I Pavlov; Gregory L Stahl; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  Circulation       Date:  2012-08-09       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.